TFAP4 and hepatocellular carcinoma: In this study, we first screened for transcription factors that bind to the 19‐bp polymorphism sequence of the LAPTM4B promoter region and found that AP4 could promote HCC tumour growth, metastasis but reduce chemotherapy sensitivity by positively regulating LAPTM4B expression.